Veltuzumab
id:
veltuzumab-268-10026342
title:
Veltuzumab
text:
Veltuzumab is a monoclonal antibody which is being investigated for the treatment of non-Hodgkin's lymphoma. As of December 2011, it is undergoing Phase I/II clinical trials. When used with milatuzumab it showed activity. This drug was developed by Immunomedics, Inc. and was originally known as IMMU-106. In August 2015 the US FDA granted it orphan drug status for immune thrombocytopenia (ITP). A phase II trial is planned to run for 5 years.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Veltuzumab
date created:
date modified:
2023-09-26T14:19:47Z
main entity:
{"identifier":"Q4009438","url":"https://www.wikidata.org/entity/Q4009438"}
image:
fields total:
13
integrity:
14